Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 01, 2023	Jun. 25, 2022
OPERATING ACTIVITIES
Net income	$ 144,754	$ 237,394
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	30,139	28,045
Non-cash interest charges	132	224
Provisions for losses on trade and other accounts receivable	7,268	6,359
Gains on sales/disposals of operating property	(2,884)	(1,213)
Deferred income taxes, net	(1,178)	5,999
Stock-based compensation	3,126	5,810
Changes in operating assets and liabilities:
Decrease (increase) in trade and other accounts receivable	103,842	(82,233)
Increase in other assets	(20,258)	(42,742)
(Decrease) increase in accounts payable	(48,684)	66,404
Decrease in other liabilities	(17,820)	(25,265)
(Decrease) increase in insurance claims	(6,704)	10,869
NET CASH PROVIDED BY OPERATING ACTIVITIES	191,733	209,651
INVESTING ACTIVITIES
Sales and maturities of investments	63,602	21,918
Purchases of investments	(55,507)	(23,883)
Purchases of operating property	(12,631)	(7,467)
Proceeds from sales of operating property	4,582	2,358
Purchase of non-marketable securities	0	(4,999)
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES	46	(12,073)
FINANCING ACTIVITIES
Decrease in cash overdraft	(35,737)	(2,875)
Dividends paid	(93,440)	(93,968)
Proceeds from exercises of stock options	28	56
Taxes paid in lieu of shares issued related to stock-based compensation plans	(9,162)	(10,269)
Purchases of common stock	(15,433)	(212,632)
Principal payments on finance lease obligations	(18,691)	(19,051)
NET CASH USED BY FINANCING ACTIVITIES	(172,435)	(338,739)
Effect of exchange rate changes on cash and cash equivalents	1,603	(190)
Increase (decrease) in cash, cash equivalents and restricted cash	20,947	(141,351)
Cash, cash equivalents and restricted cash at beginning of period	339,581	219,571
Cash and cash equivalents at end of period	$ 360,528	$ 78,220